Swissport demonstrates pharma skills

Written by: Alwyn Brice |
Comment on this article

Around the world Swissport has been busy establishing operational readiness for the handling of highly temperature-sensitive vaccines.

Vaccines, and indeed many pharmaceuticals, require rigorous temperature control throughout the entire supply chain. While some types of COVID-19 vaccines might only call for temperatures around -20°C or in a range from 2° to -8°C, others will very likely require extremely low temperatures in the range of -70°C.

Today, in collaboration with Brussels airport, Air Cargo Belgium and Hazgo, Swissport demonstrated its ability to handle highly temperature-sensitive air cargo at its state-of-the-art 3,620 square metre Pharma Centre in Brussels. Two separate shipments were delivered to the facility, which is part of an end-to-end cool chain. One shipment arrived in a container cooled to -70°C, while the other shipment was transported in a more conventional 2° to -8°C temperature range. Swissport’s top-notch infrastructure, combined with know-how regarding dry ice handling, allowed for a seamless temperature control throughout the entire airport handling process, from the acceptance at the cargo warehouse to the transport on the apron with special vehicles - and right into the aircraft.

This material is protected by The Airports Publishing Network Ltd copyright see Terms and Conditions.
One-off usage is permitted but bulk copying is not. For multiple copies contact


Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code